US$ 22.01
retatrutide and pregnancy Retatrutide Dosage Guide 2026: Phase
Description
GLP-1 medications approved to treat type 2 diabetes include: There was a follow-up period of 3 months to 2 years after the discontinuation of the use of GLP-1 medications

Additional support For details about your medication and dosing, please log in to your patient portal

The theoretical concern based on animal data has not materialised in clinical practice

The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) analyzes your peptide-pathway genetics across 150+ insights, helping your provider decide whether you're a candidate for 6-month intensive therapy, 1224 month standard duration, or long-term maintenance

Peters H, Potla P, Rockel JS, Tockovska T, Pastrello C, Jurisica I, et al
The information provided reflects publicly available details from the company's website and general industry context